ALT logo

Altimmune, Inc. (ALT)

Profile

Full Name

Altimmune, Inc.

Ticker

NASDAQ: ALT

Exchange

NASDAQ

Country

United States

IPO

May 26, 2017

Indexes

Not included

Employees

59

Key Details

Price

$5.10(6.03%)

Annual Revenue

$20.00K(-95.31% YoY)

Annual EPS

-$1.34(19.40% YoY)

Next earnings date

Feb 26, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Nov 7, 25 Citizens
Market Outperform
Oct 20, 25 HC Wainwright & Co.
Buy
Oct 10, 25 HC Wainwright & Co.
Buy
Aug 13, 25 UBS
Buy
Aug 13, 25 HC Wainwright & Co.
Buy
Aug 13, 25 B. Riley Securities
Buy
Jul 10, 25 JMP Securities
Market Outperform
Jun 27, 25 HC Wainwright & Co.
Buy
Apr 3, 25 HC Wainwright & Co.
Buy
Apr 2, 25 Citizens Capital Markets
Market Outperform

Institutional Ownership

  • What is the ticker symbol for Altimmune, Inc.?
  • Does Altimmune, Inc. pay dividends?
  • What sector is Altimmune, Inc. in?
  • What industry is Altimmune, Inc. in?
  • What country is Altimmune, Inc. based in?
  • When did Altimmune, Inc. go public?
  • Is Altimmune, Inc. in the S&P 500?
  • Is Altimmune, Inc. in the NASDAQ 100?
  • Is Altimmune, Inc. in the Dow Jones?
  • When was Altimmune, Inc.'s last earnings report?
  • When does Altimmune, Inc. report earnings?

What is the ticker symbol for Altimmune, Inc.?

The ticker symbol for Altimmune, Inc. is NASDAQ:ALT

Does Altimmune, Inc. pay dividends?

No, Altimmune, Inc. does not pay dividends

What sector is Altimmune, Inc. in?

Altimmune, Inc. is in the Healthcare sector

What industry is Altimmune, Inc. in?

Altimmune, Inc. is in the Biotechnology industry

What country is Altimmune, Inc. based in?

Altimmune, Inc. is headquartered in United States

When did Altimmune, Inc. go public?

Altimmune, Inc.'s initial public offering (IPO) was on May 26, 2017

Is Altimmune, Inc. in the S&P 500?

No, Altimmune, Inc. is not included in the S&P 500 index

Is Altimmune, Inc. in the NASDAQ 100?

No, Altimmune, Inc. is not included in the NASDAQ 100 index

Is Altimmune, Inc. in the Dow Jones?

No, Altimmune, Inc. is not included in the Dow Jones index

When was Altimmune, Inc.'s last earnings report?

Altimmune, Inc.'s most recent earnings report was on November 6, 2025

When does Altimmune, Inc. report earnings?

The next expected earnings date for Altimmune, Inc. is February 26, 2026
On this page